Impact of Glycosylation on Effector Functions of Therapeutic IgG
Human IgG has only one conserved glycosylation site located in the Cγ2 domain of the Fc region that accounts for the presence of two sugar moieties per IgG. These IgG sugar cores play a critical role in a number of IgG effector functions. In the present review, we describe the main characteristics o...
Saved in:
Main Authors: | Jean-Luc Teillaud (Author), Riad Abès (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157)
by: Andreas Nechansky, et al.
Published: (2010) -
Multivariate quantitative analysis of glycan impact on IgG1 effector functions
by: Tamara Cvijić, et al.
Published: (2024) -
Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis
by: I. Magorivska, et al.
Published: (2018) -
Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG
by: Ercan Altan, et al.
Published: (2012) -
Engineered Fc-glycosylation switch to eliminate antibody effector function
by: Qun Zhou, et al.
Published: (2020)